As COVID-19 restrictions ease nationwide and occupancy levels begin to rise, investing in a high-efficiency particulate air (HEPA) purifier might be beneficial.
According to News-Medical, several published studies evaluating aerosols and submicron particles similar in size to the SARS-CoV-2 virion have shown that portable HEPA purifiers can significantly reduce airborne COVID-19 particles.
Ahmad Sedaghat, a University of Cincinnati College of Medicine researcher, identified the medical literature showing published studies on the effectiveness of HEPA purifiers. Air purifiers could benefit hospitals and physician offices where aerosol-generating procedures occur, but they are also useful for reducing COVID-19 transmission anywhere that large groups of individuals congregate.
IAQ and Infection Mitigation: Plans Into Actions
Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy
Dayton Children's Hospital Announces New Rehabilitative Services Building
The Debate on Laundering Microfibers in Healthcare
Construction Begins for New Cancer Center at OhioHealth's Administrative Campus